Skip to main content
Premium Trial:

Request an Annual Quote

Sysmex Inks Global Deal with Streck

NEW YORK (GenomeWeb) – Sysmex Corporation has signed an agreement with Streck to include two Streck blood collection tubes as part of Sysmex's medical diagnostics products and services.

Under the terms of the deal, Streck — a developer and manufacturer of products for clinical and research labs — will supply Sysmex with cell-free DNA blood collection tubes: Cell-Free DNA BCT and Cell-Free DNA BCT CE.

Financial terms of the agreement were not disclosed.

The collection tubes will be distributed with products and services associated with Sysmex Corporation subsidiary Sysmex Inostics' OncoBEAM assays for mutation analysis of circulating tumor DNA.

"Our internal studies have shown that Streck Cell-Free DNA BCT blood collection tubes are ideal for stabilizing cell-free DNA to allow for efficient and effective collection and transport of specimens at ambient temperatures," Vishal Sikri, vice president of commercial operations at Sysmex Inostics, said in a statement.

The agreement is the latest in more than three decades of partnerships between Streck and Sysmex, the companies noted. "Our new agreement with Sysmex supports the collaboration of that long-term partnership and the expansion of our product portfolio," added Streck President and CEO Connie Ryan.

The Scan

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.

Meta AI Computer Model Rapidly Predicts Hundreds of Millions of Metagenomic Proteins

Meta AI researchers describe in Science a new large language model that can predict the structures of millions of metagenomic proteins.

Hutch Team Develops Platform for Assessing Impact of SARS-CoV-2 Spike Mutations

The approach described in Cell relies on lentiviral pseudotyping for mutational scanning, which the researchers applied to the SARS-CoV-2 spike protein.

Potential New Therapeutic Target for Rheumatoid Arthritis Discovered

Researchers report in the American Journal of Human Genetics that SNPs implicated in rheumatoid arthritis often regulate the expression of the inflammation-related SPRED2 gene.